0.7719
Precedente Chiudi:
$0.7392
Aprire:
$0.7729
Volume 24 ore:
2.21M
Relative Volume:
0.17
Capitalizzazione di mercato:
$28.04M
Reddito:
-
Utile/perdita netta:
$-23.36M
Rapporto P/E:
-1.0476
EPS:
-0.7368
Flusso di cassa netto:
-
1 W Prestazione:
+25.33%
1M Prestazione:
+196.77%
6M Prestazione:
+4.07%
1 anno Prestazione:
-53.83%
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Nome
Calidi Biotherapeutics Inc
Settore
Industria
Telefono
(858) 794-9600
Indirizzo
4475 Executive Drive, Suite 200, San Diego
Confronta CLDI con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CLDI
Calidi Biotherapeutics Inc
|
0.7719 | 25.52M | 0 | -23.36M | 0 | -0.7368 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-11-22 | Iniziato | H.C. Wainwright | Buy |
2023-10-09 | Iniziato | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Borsa (CLDI) Ultime notizie
What analysts say about Calidi Biotherapeutics Inc. stockTriple-digit profit margins - jammulinksnews.com
What drives Calidi Biotherapeutics Inc. stock priceDouble or triple returns - Autocar Professional
Calidi Biotherapeutics Inc. Stock Analysis and ForecastRapid return acceleration - jammulinksnews.com
Is Calidi Biotherapeutics Inc. a good long term investmentDynamic investment opportunities - jammulinksnews.com
40-Year Biotech Veteran Jim Schoeneck Joins Connect Biopharma Board as Asthma Drug Enters Critical Phase - Stock Titan
Calidi Biotherapeutics Invites Investors to Webinar on Precision Genetic Medicine Advances - Nasdaq
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on July 24 - GlobeNewswire
What risks could impact Calidi Biotherapeutics Inc. stock performanceFree Stock Trading Community - Newser
What makes Calidi Biotherapeutics Inc. stock price move sharplyFree Professional Portfolio Management - Newser
Why Calidi Biotherapeutics Inc. stock attracts strong analyst attentionFree Best Performing Stock Suggestions - Newser
How Calidi Biotherapeutics Inc. stock performs during market volatilityMarket Beating Strategy - Newser
Calidi Biotherapeutics Inc Inc. (CLDI) Price Performance: A Comparative Analysis with Competitors - investchronicle.com
Calidi Biotherapeutics Approves Key Proposals at Annual Meeting - TipRanks
Calidi Biotherapeutics Plummets 27%—Can Biotech Breakthroughs Stem the Slide? - AInvest
Calidi Biotherapeutics Plunges 4.81% Amid Bridge Financing - AInvest
Top Penny Stocks To Add to Your Watchlist – July 9th - Defense World
Small Cap Stocks Worth Watching – July 9th - Defense World
Calidi Biotherapeutics Announces Inducement Offer Agreement - TipRanks
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up - Quantisnow
Calidi Biotherapeutics: Redefining Cancer Treatment with Breakthrough Virotherapy - AInvest
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment - The Manila Times
Breakthrough Cancer Treatment: Calidi's New Genetic Platform Targets Both Primary and Metastatic Tumors - Stock Titan
3 Penny Stocks to Watch Now, 7/10/25 - TipRanks
Calidi Biotherapeutics Cashes In On Warrant Agreement - Finimize
Calidi Biotherapeutics secures $4.6 million through warrant exercise - Investing.com Australia
Calidi Biotherapeutics secures $4.6 million through warrant exercise By Investing.com - Investing.com Nigeria
Calidi Biotherapeutics to Raise $4.6 Million Through Warrant Exercise Agreement - MarketScreener
Calidi Biotherapeutics Inc Azioni (CLDI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Capitalizzazione:
|
Volume (24 ore):